Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
NephU Community Advisors, Dr Neera Dahl, Dr Arlene Chapman, and Dr Frederic F. Rahbari Oskoui present an overview of autosomal dominant polycystic kidney disease (ADPKD) and answer common questions health care professionals have about ADPKD.
NephU Community Advisors, Dr Neera Dahl, Dr Arlene Chapman, and Dr Frederic F. Rahbari Oskoui present an overview of autosomal dominant polycystic kidney disease (ADPKD) and answer common questions health care professionals have about ADPKD.
NephU Community Advisors, Dr Neera Dahl, Dr Arlene Chapman, and Dr Frederic F. Rahbari Oskoui present an overview of autosomal dominant polycystic kidney disease (ADPKD) and answer common questions health care professionals have about ADPKD.
In this virtual live event, Alf Carroll, MS, PA-C, and Alyssa Peckham, PharmD, BCPP discuss the high prevalence of major depressive disorder (MDD) among patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).
Please join us as leading experts, James Calvet, PhD and Arlene Chapman, MD, take us on a journey of the past discoveries, clinical advancements made, and the present state of affairs in the PKD research field with the NephU webinar titled, “Polycystic Kidney Disease Research – Past, Present and Future: Part I.”
Please join us as leading experts, James Calvet, PhD and Arlene Chapman, MD, take us on a journey of the past discoveries, clinical advancements made, and the present state of affairs in the PKD research field with the NephU webinar titled, “Polycystic Kidney Disease Research – Past, Present and Future: Part I.”
In this Part 1 of a 3 Part series, we will briefly describe the pathophysiology of Autosomal Dominant Polycystic Kidney Disease (ADPKD) including its cellular, metabolic, and systemic impact. Then, we will discuss the nutritional/diet management strategies for ADPKD, with an emphasis on using the Ketogenic Diet. We will set the stage for Part 2, describing a Plant-Focused Ketogenic Diet Program for improved ADPKD outcomes.
In this Part 1 of a 3 Part series, we will briefly describe the pathophysiology of Autosomal Dominant Polycystic Kidney Disease (ADPKD) including its cellular, metabolic, and systemic impact. Then, we will discuss the nutritional/diet management strategies for ADPKD, with an emphasis on using the Ketogenic Diet. We will set the stage for Part 2, describing a Plant-Focused Ketogenic Diet Program for improved ADPKD outcomes.
Watch a rebroadcast of this virtual panel discussion, led by nephrology experts, where you can hear about the racial disparities that exist in autosomal dominant polycystic kidney disease.
Watch a rebroadcast of this virtual panel discussion, led by nephrology experts, where you can hear about the racial disparities that exist in autosomal dominant polycystic kidney disease.
Watch a rebroadcast of this virtual panel discussion, led by nephrology experts, where you can hear about the racial disparities that exist in autosomal dominant polycystic kidney disease.
Join us for part 2 of this informative international webinar where Professor Andrew Mallett, nephrologist and clinical researcher (Australia), and Dr Hila Rasouly, research scientist and genetic counselor (USA), discuss clinical genomics and its applications in kidney disease, including genetic testing for diagnosis and prognosis and the question of determining which patients to test, barriers to access, global differences across healthcare landscapes, and implications for the patient.
